Test Price
2,800 AED✅ Home Collection Available
HSPA9 Gene Analysis (Sideroblastic Anemia Type 4) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
The HSPA9 Gene Analysis (Sideroblastic Anemia Type 4) Genetic Test employs Next-Generation Sequencing (NGS) to detect pathogenic variants in the HSPA9 gene, delivering high diagnostic accuracy for hereditary sideroblastic anemia type 4. This test supports precise genetic counselling and clinical management in full compliance with Dubai Healthcare City Authority (DHCA) and DHA regulatory standards.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance and genetic counselling included.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The HSPA9 Gene Analysis (Sideroblastic Anemia Type 4) Genetic Test sequences the entire coding region of the HSPA9 gene using Next-Generation Sequencing (NGS) to identify pathogenic variants associated with microcytic, hypochromic anaemia and ring sideroblasts in the bone marrow. This test is suitable for patients with suspected hereditary sideroblastic anaemia type 4, carrier screening, and prenatal diagnosis.
| Feature | Our Test (HSPA9 NGS) | Closest Alternative (Sanger Sequencing Panel) |
|---|---|---|
| Precision | 99.9% analytical sensitivity, full gene coverage | ~95% sensitivity, limited to hotspot regions |
| Methodology | Next-Generation Sequencing (NGS), ISO-15189 accredited | Sanger sequencing, lower throughput |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
| Price (AED) | 2,800 AED | 3,200 AED |
Physician Insight & Safety Protocols
"Genetic testing for hereditary sideroblastic anaemia requires meticulous interpretation within the context of full haematological and clinical history. The HSPA9 gene analysis provides critical insight for affected families, yet results must never drive therapeutic decisions in isolation. Always correlate with bone marrow morphology, iron studies, and peripheral blood indices before concluding management plans."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Critical Advisory
Do not discontinue or alter prescribed medication without consulting your treating physician. This test is a diagnostic aid, not a standalone treatment guide.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active febrile illness or acute infection at the time of blood draw (postpone collection until recovery to avoid confounding factors).
- Exclusion Criteria: Recent blood transfusion within 2 weeks (may temporarily alter genetic material analysis).
- Emergency Red Flags: If you experience severe pallor, exertional dyspnoea, tachycardia, or chest pain, seek immediate emergency care — do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the HSPA9 Gene Analysis for Sideroblastic Anemia Type 4?
Snippet: The HSPA9 Genetic Test detects mutations in the HSPA9 gene responsible for hereditary sideroblastic anemia type 4, guiding accurate diagnosis and family planning.
This test sequences the entire coding region of the HSPA9 gene using Next-Generation Sequencing to identify pathogenic variants associated with microcytic, hypochromic anaemia and ring sideroblasts in the bone marrow. It is suitable for patients with suspected hereditary sideroblastic anaemia type 4, carrier screening, and prenatal diagnosis.
2. How should I prepare for this genetic test and what sample is required?
Snippet: No fasting is required; you can provide a whole blood sample, extracted DNA, or a single drop of blood on an FTA card collected by our mobile team.
A genetic counselling session is mandatory prior to testing to draw a pedigree of affected family members and discuss potential outcomes. Our team will schedule a convenient 8 AM – 11 PM home visit, collect the sample using temperature-controlled cold-chain logistics, and deliver it to the laboratory. Avoid heavy physical exercise and alcohol 24 hours before the draw. No medication changes are needed unless advised by your doctor.
3. Why choose this HSPA9 genetic test at DNA Labs UAE under DHA regulation?
Snippet: DNA Labs UAE operates under strict DHA Facility License 1143 with ISO-accredited precision, licensed genetic interpretation, and full compliance with UAE genetic testing regulations.
Our facility is licensed by the Dubai Health Authority (DHA License 1143) and physically located in Dubai Healthcare City. All genetic counselling and result reporting adhere to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 on Health ICT. Home collection is performed by licensed phlebotomists following strict cold-chain protocols, and your genetic data is stored with enterprise-grade encryption.
4. What is the turnaround time and pricing for this test?
Snippet: The test costs 2,800 AED with results delivered within 3 to 4 weeks from sample receipt at the laboratory.
Pricing includes the full NGS analysis, genetic counselling session, and a comprehensive clinical report. Direct billing with major insurance providers is available — verify your coverage via WhatsApp at +971 54 548 8731. The turnaround time reflects the complexity of NGS sequencing and confirmatory Sanger validation where required.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
- DHA Facility License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
- Data Protection: Full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – all genetic data processed, stored, and transmitted with encryption and access controls.
- Health ICT Compliance: Adherence to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for secure health data exchange.
- Clinical Safety: Patient consent and clinical liability protections under Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Methodology Standard: Next-Generation Sequencing (NGS) validated per ISO 15189 standards for clinical genetic testing.
Clinical & Logistical Metadata
| Test Name | HSPA9 Gene Analysis (Sideroblastic Anemia Type 4) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS), ISO 15189 validated |
| ICD-10-CM Code | D64.0 (Hereditary sideroblastic anemia), Z15.09 (Genetic susceptibility to other disease), Z14.8 (Genetic carrier of other disease) |
| LOINC Code | 81247-9 (HSPA9 gene mutations found in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians